Nivolumab-induced diabetes mellitus—a case report with literature review of the treatment options

Nivolumab-induced diabetes mellitus—a case report with literature review of the treatment options

BackgroundImmune checkpoint inhibitor (ICI) treatment has become important for treating various cancer types, including metastatic renal cell carcinoma. However, ICI treatment can lead to endocrine immune-related adverse events (irAEs) by overstimulating the patient’s immune system. Here, we report...

Full description

Bibliographic Details
Main Authors: Eveline Daetwyler, Alfred Zippelius, Simona Danioth, Marc Y. Donath, Lara Gut
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitor (ICI)
immune-related adverse event (irAE)
diabetes mellitus
TNF blockade
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1248919/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1248919/full

Similar Items